{"id":97566,"date":"2019-10-18T02:02:47","date_gmt":"2019-10-18T09:02:47","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/10\/insilico-signs-200m-ai-drug-discovery-partnership-with-chinas-ctfh"},"modified":"2019-10-18T02:02:47","modified_gmt":"2019-10-18T09:02:47","slug":"insilico-signs-200m-ai-drug-discovery-partnership-with-chinas-ctfh","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/10\/insilico-signs-200m-ai-drug-discovery-partnership-with-chinas-ctfh","title":{"rendered":"Insilico signs $200M AI drug discovery partnership with China\u2019s CTFH"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/insilico-signs-200m-ai-drug-discovery-partnership-with-chinas-ctfh.jpg\"><\/a><\/p>\n<p>Shortly after publishing a paper demonstrating how its artificial intelligence programs could generate viable lead compounds in just a few weeks, Insilico Medicine has signed a dual-program discovery collaboration with Jiangsu Chia Tai Fenghai Pharmaceutical worth up to $200 million.<\/p>\n<p>Focused on previously undruggable targets in triple-negative breast cancer, the deal includes an upfront payment along with potential milestones and sales-based royalties pegged to any eventual products.<\/p>\n<p>\u201cWe are very pleased to establish the partnership with Insilico Medicine, entering the new era of AI-enabled drug development,\u201d Wenyu Xia, general manager of the China-based pharma company, said in a statement. \u201cWe look forward to a long-term partnership with Insilico Medicine.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shortly after publishing a paper demonstrating how its artificial intelligence programs could generate viable lead compounds in just a few weeks, Insilico Medicine has signed a dual-program discovery collaboration with Jiangsu Chia Tai Fenghai Pharmaceutical worth up to $200 million. Focused on previously undruggable targets in triple-negative breast cancer, the deal includes an upfront payment [\u2026]<\/p>\n","protected":false},"author":537,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,6],"tags":[],"class_list":["post-97566","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/97566","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/537"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=97566"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/97566\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=97566"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=97566"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=97566"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}